Xiangmei Chen
Chinese PLA General Hospital · Chinese PLA General Hospital, Beijing, China · The General Hospital of the People's Liberation Army (PLAGH)
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Xiangmei Chen as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 04:51 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT07045155 · Pegmolesatide Treatment for Anemia in Patients Undergoing Long-term DialysisChinese PLA General Hospital · recruiting · Dialysis; Complications, Chronic Kidney Disease 5D, Renal Anemia of Chronic Kidney Disease · principal investigator
- Early Ph1NCT06690359 · IM19 CAR-T Cell Therapy for IgA Nephropathy Patients and Membranous Nephropathy PatientsBeijing Immunochina Medical Science & Technology Co., Ltd. · not yet recruiting · IgA Nephropathy, Membranous Nephropathy · principal investigator
- Ph4NCT06660940 · Clinical Trial of Keluoxin Capsules in the Treatment of Diabetic Kidney Disease with Diabetic RetinopathyChinese PLA General Hospital · not yet recruiting · Diabetic Kidney Disease, Diabetic Retinopathy · principal investigator
- Early Ph1NCT06485648 · Mesenchymal Stem Cell Transfusion for the Treatment of Refractory Lupus NephritisChinese PLA General Hospital · not yet recruiting · Lupus Nephritis · principal investigator
- Ph4NCT05839314 · Effect of Huaier Granule on the Treatment of Idiopathic Membranous NephropathyChinese PLA General Hospital · recruiting · Nephropathy, Glomerular Diseases, Idiopathic Membranous Nephropathy · principal investigator
- N/ANCT05738525 · Comparative Study of Prognosis and QOL Between APD-RPM and CAPDChinese PLA General Hospital · recruiting · End-stage Renal Disease · principal investigator
- Ph3NCT05211167 · Phase III Clinical Study of Recombinant Erythropoiesis Stimulating Protein Injection (rESP) in the Treatment of Anemia in Hemodialysis Patients With Chronic Renal FailureShenyang Sunshine Pharmaceutical Co., LTD. · unknown · Kidney Failure, Chronic, Hemodialysis · principal investigator
- Ph3NCT03984760 · Ferric Citrate for the Treatment of Hyperphosphatemia in Patients With Chronic Kidney Disease Undergoing HemodialysisPanion & BF Biotech Inc. · completed · Hyperphosphatemia, End Stage Renal Disease, ESRD · principal investigator
- N/ANCT03865914 · Correlation Study Between Clinical Phenotype and Pathology of Type 2 Diabetic NephropathyChinese PLA General Hospital · recruiting · Diabetic Kidney Disease · principal investigator
- N/ANCT03246191 · Screening and Assessing the Risk Factors and Complications of Chronic Kidney DiseaseChinese PLA General Hospital · unknown · Chronic Kidney Disease · principal investigator
- N/ANCT03246204 · Chinese Observational Prospective Study of Aging Population With Chronic Kidney Disease(C-OPTION)Chinese PLA General Hospital · unknown · Chronic Kidney Disease · principal investigator
- Ph4NCT02231125 · Efficacy and Safety of Abelmoschus Manihot for IgA NephropathyChen Xiangmei · unknown · IgA Nephropathy · principal investigator
- Ph4NCT02231138 · Efficacy and Safety of Abelmoschus Manihot for Chronic Kidney DiseaseChinese PLA General Hospital · unknown · Chronic Kidney Disease · principal investigator
- Ph4NCT02063100 · Efficacy and Safety of Shenyankangfu Tablets for Primary GlomerulonephritisChinese PLA General Hospital · unknown · Glomerulonephritis, Proteinuria · principal investigator
- N/ANCT01947829 · Interdialytic Kt/V Variability Measurement With Adimea (IVP STUDY)B.Braun Avitum AG · completed · Kidney Disease · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 04:51 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 04:51 UTC. The ranking covers the 200 most relevant of 2940 PubMed records, and a shared surname and initials can bring in a namesake. All 2940 on PubMed
- Benmelstobart, anlotinib and chemotherapy in extensive-stage small-cell lung cancer: a randomized phase 3 trial.Nat Med · 2024145 citationsRCR 14.6
- 116 citationsRCR 29.0
- 87 citationsRCR 9.3
- 77 citationsRCR 15.8
- Drug-Coated Balloon Angioplasty of the Side Branch During Provisional Stenting: The Multicenter Randomized DCB-BIF Trial.J Am Coll Cardiol · 202570 citationsRCR 26.5
- 59 citationsRCR 9.6
- First-Line Lenvatinib Plus Pembrolizumab Versus Chemotherapy for Advanced Endometrial Cancer: A Randomized, Open-Label, Phase III Trial.J Clin Oncol · 202557 citationsRCR 12.5
- Stapokibart for moderate-to-severe seasonal allergic rhinitis: a randomized phase 3 trial.Nat Med · 202550 citationsRCR 16.8
- Efficacy and Safety of Nemolizumab in Patients With Moderate to Severe Prurigo Nodularis: The OLYMPIA 1 Randomized Clinical Phase 3 Trial.JAMA Dermatol · 202548 citationsRCR 16.6
- Effects of Web-Based Acceptance and Commitment Therapy on Health-Related Outcomes Among Patients With Lung Cancer: A Feasibility Randomized Controlled Trial.Psychooncology · 202444 citationsRCR 7.6